The MPN News feed provides frequent updates on the latest happenings in the MPN World. Fresh content, with brief summary is automatically updated frequently from reliable sources. Just click on the red hyperlink to pull up the complete news item.
Make PV Reporter your “starting point” for all MPN related news.
- Treatment Options Expand Beyond JAK Inhibition for Patients With MFby mpn_admin at 1:55 pm
The only curative approach to treating myelofibrosis (MF) at this time is hematopoietic stem cell transplant, but the treatment landscape […]
- Industry Partner Updatesby mpn_admin at 4:29 pm
Please view the updates from MPN Advocacy & Education International's Industry Partners. The post Industry Partner Updates appeared […]
- Bone Fracture Risk Increased in Patients With MPNsby mpn_admin at 2:15 pm
Results of a retrospective analysis showed a significantly elevated risk of bone fractures in a population-based cohort of patients […]
- 6th Annual Women & MPN Webinarby mpn_admin at 3:20 pm
The 6th Annual Women & MPN Conference was held via webinar on September 25, 2020. Click the video below to view the program. Speakers […]
- October 17, 2020 – Living Well During AML Treatmentby JOANN MANNINO at 8:08 pm
Overview Want to learn more about the latest treatment options for acute myeloid leukemia? Join us for a virtual town meeting for AML […]
- October 28, 2020 – International Patient Symposium on Myeloproliferative Neoplasmsby JOANN MANNINO at 5:14 pm
JOIN US FOR THE 11th INTERNATIONAL PATIENT SYMPOSIUM ON MYELOPROLIFERATIVE NEOPLASMS (MPNs) – A FREE VIRTUAL EVENT WEDNESDAY, OCTOBER 28, […]
- MPN Education Foundation/MPN-NET Speaker Event – Thursday, September 10th, 2020by mpnadmin at 12:16 am
The MPN EDUCATION FOUNDATION and MPN-NET presented a patient event hosted by Dr. Ruben Mesa, with guest presentations from Dr. Claire […]
- Constellation Pharmaceuticals Updates MANIFEST Trialby mpn_admin at 6:51 pm
Constellation has aligned with the FDA on the design of MANIFEST-2, the pivotal Phase 3 clinical trial for CPI-0610 expected to begin in […]
- Imago BioSciences granted access to European PRIME Schemeby mpn_admin at 2:08 pm
The European Medicines Agency (EMA) granted Imago BioSciences access to its PRIME (PRIority MEdicines) scheme for IMG-7289 (bomedemstat) a […]
- 8 updates on COVID-19 drugs in developmentby mpn_admin at 2:14 pm
Hundreds of clinical trials in the U.S. and abroad are looking for potential drugs to treat or prevent COVID-19. As of July 6, […]
- Ruxolitinib’s Impact on OS in the Real World for Elderly Patients Diagnosed With MFby mpn_admin at 3:36 pm
In the real-world, ruxolitinib’s approval to treat myelofibrosis has improved overall survival (OS) for elderly patients. Two abstracts […]
- Protagonist Therapeutics Receives Orphan Drug Status for PTG-300 in Treatment of PVby mpn_admin at 2:45 pm
The U.S. Food and Drug Administration granted orphan-drug status to Protagonist Therapeutics Inc.’s PTG-300 to treat a rare form of blood […]
- MPN QOL Surveyby mpnadmin at 2:13 pm
The Mayo Clinic and Myeloproliferative Neoplasm Quality of Life Study Group are conducting an international research survey to investigate […]
- EHA Poster: Sierra Oncology Reports Favorable Long-Term Safety and Dose Intensity Data for Momelotinibby mpn_admin at 2:32 pm
Data presented at the 25th European Hematology Association (EHA) Virtual Congress further demonstrate the potential anemia benefits and […]
- Dr. Mesa and Antje Hjerpe discuss Treatment for ETby mpnadmin at 7:08 pm
The post Dr. Mesa and Antje Hjerpe discuss Treatment for ET appeared first on MPN Education Foundation.
